Dr Mohamed Abdelghani is one of the best known psychiatrists in London who specialises in treating depression. He is credited for being one of the driving forces introducing innovative evidence-based treatment to clinical practice in the UK.

Dr Abdelghani is currently serving as the President of the Clinical TMS Society (CTMSS). The CTMSS is the largest TMS professional association in the world. The work of the society is dedicated to optimising clinical practice, awareness, and accessibility of Transcranial Magnetic Stimulation therapy. He is the first person from outside the USA to be elected to this position and before that he served in various leadership positions in the CTMSS. He was Vice-President of the society for a year, Secretary for 2 years and has been a member of the Board of Directors of the society since 2017.

In 2016, Dr Abdelghani founded the first clinical TMS service in the NHS in London and South England at Camden and Islington NHS Foundation Trust and he continues to lead this service until the present time. He has been formally trained in TMS at two of the top TMS centres in the world; Harvard University in USA and Medical University of South Carolina (MUSC).

Dr Abdelghani established his private practice, Dyad Medical, in Harley Street in London in 2015. In 2020 he expanded his private practice by adding two new services; London TMS Centre and London Esketamine Clinic. Through these two new services his team offers TMS and Esketamine to private patients who suffer with treatment-resistant or difficult to treat depression. In 2020 he became the first psychiatrist in the UK to treat a patient using Esketamine nasal spray in the private sector. His innovative work also included treating patients suffering with Alzheimer’s disease using Transcranial Pulse Stimulation (TPS). He did this through creating an Old Age clinical pathway in Dyad Medical in 2022 under the name, London Alzheimer’s Clinic. Dyad Medical was the first place in the UK to offer this novel treatment to patients suffering with Alzheimer’s disease.

Dr Abdelghani has been working as a Consultant Psychiatrist in the NHS since 2013. He has been a consultant psychiatrist at Camden & Islington NHS Foundation Trust in Central London since 2014. He holds two clinical excellence awards from the Trust for his work on improving NHS services and providing high quality care. Dr Abdelghani completed his post-graduate psychiatric training at South London & Maudsley NHS Foundation trust (SLaM) which is the biggest mental health trust in the UK, a centre of excellence and one of the most influential mental health organisations in the world. After finishing his higher psychiatry training at SLaM he worked as a consultant psychiatrist for almost a year at the same organisation before taking on his current post at Camden & Islington NHS Foundation Trust with the aim of developing highly specialised depression services.

Dr Abdelghani is actively involved in TMS clinical research with the aim of making TMS treatment more efficient and more accessible to different groups of patients. He was the London Principal Investigator for the BRIGhTMIND TMS Randomised Control Trial (RCT).

In 2009 Dr Abdelghani became a member of the Royal College of Psychiatrists, in 2012 he obtained MSc in Clinical Neuroscience from King’s College London, in 2020 he was elected to become a fellow of the Royal College and 2022 he was awarded the fellowship of the Clinical TMS Society.